Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.60%54.89M | 65.69%278.81M | 28.80%62.65M | 8.81%46.55M | 46.46%64.76M | 77.42%168.27M | 1,831.03%48.64M | 57.68%49.63M | 50.49%42.78M | 17.11%44.21M |
| Cost of revenue | -9.78%46.14M | 53.38%211.6M | 143.59%43.9M | -24.10%30.43M | 45.96%49.32M | 10.63%137.96M | -20.70%18.02M | 64.94%51.14M | 19.68%40.09M | -9.84%33.79M |
| Gross profit | 676.91%8.75M | 121.73%67.22M | -38.76%18.75M | 498.66%16.12M | 48.11%15.44M | 201.50%30.31M | 219.91%30.62M | -425.32%-1.52M | 153.13%2.69M | 3,704.01%10.42M |
| Operating expense | 91.14%-2.17M | 542.17%30.09M | 0.23%6.97M | -0.85%9.49M | -48.75%6.85M | -113.70%-6.8M | -72.40%6.95M | -390.00%-24.51M | -0.25%9.57M | 107.18%13.36M |
| Selling and administrative expenses | -77.66%7.77M | -47.69%37.91M | -32.25%8.1M | -18.57%10.03M | -30.09%10.22M | 45.90%72.47M | -33.44%11.96M | 208.57%34.8M | 10.63%12.32M | 57.32%14.62M |
| -General and administrative expense | -77.66%7.77M | -47.69%37.91M | -32.25%8.1M | -18.57%10.03M | -30.09%10.22M | 45.90%72.47M | -33.44%11.96M | 208.57%34.8M | 10.63%12.32M | 57.32%14.62M |
| Total other operating income | -83.23%9.94M | -90.13%7.82M | -77.35%1.13M | -80.17%546K | 168.18%3.37M | --79.27M | --5.01M | 1,997.10%59.31M | 78.19%2.75M | -55.79%1.26M |
| Operating profit | -52.51%10.92M | 0.03%37.13M | -50.20%11.79M | 196.57%6.64M | 392.34%8.59M | 146.67%37.12M | 146.67%23.67M | 387.94%22.99M | 53.11%-6.87M | 52.42%-2.94M |
| Net non-operating interest income (expenses) | -4.38%-9.46M | 26.68%-29.37M | 56.87%-6.72M | -15.10%-6.85M | 10.79%-7.06M | -32.51%-40.05M | -157.79%-15.57M | 2.73%-9.06M | 5.54%-5.95M | 7.69%-7.91M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | -3.28%2.39M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 4.38%9.46M | -26.68%29.37M | -56.87%6.72M | 15.10%6.85M | -10.79%7.06M | 137.77%40.05M | 312.04%15.57M | -2.73%9.06M | -5.54%5.95M | -7.69%7.91M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | 16.43%18.45M | ---- | ---- | ---- | ---- |
| Net investment income | 5,642.42%1.9M | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 55.56%112K | 209.41%2.45M | 149.19%1.45M | 302.51%1.6M | -363.16%-700K | -311.21%-2.24M | -1,705.43%-2.95M | -88.61%72K | 696.00%398K | 35.71%266K |
| Special income (charges) | 630.24%55.39M | |||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -12,319.18%-60.23M | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | -55.69%4.84M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -271.18%-12.69M | |||||||||
| Income before tax | -88.78%1.57M | 297.47%10.22M | 26.75%6.53M | 111.15%1.39M | 107.88%834K | 95.78%-5.18M | 107.31%5.15M | 183.99%14M | 40.57%-12.43M | 27.27%-10.58M |
| Income tax | 117.92%69K | -72.25%1.55M | -81.18%628K | -90.13%79K | -60.08%689K | 54.37%5.58M | 132.38%3.34M | -376.98%-385K | -15.16%800K | 57.19%1.73M |
| Net income | -89.56%1.5M | 180.60%8.67M | 225.62%5.9M | 109.88%1.31M | 101.18%145K | 91.47%-10.76M | 102.52%1.81M | 185.58%14.38M | 39.47%-13.23M | 21.34%-12.31M |
| Net income continuous operations | -89.56%1.5M | 180.60%8.67M | 225.62%5.9M | 109.88%1.31M | 101.18%145K | 91.47%-10.76M | 102.52%1.81M | 185.58%14.38M | 39.47%-13.23M | 21.34%-12.31M |
| Noncontrolling interests | 87.91%1.03M | 41.38%6.02M | 254.17%5.14M | -100.31%-6K | 18.27%1.48M | 233.67%4.26M | 115.03%1.45M | -86.13%546K | 667.19%1.94M | -45.19%1.25M |
| Net income attributable to the company | -96.57%475K | 117.63%2.65M | 110.56%758K | 108.66%1.31M | 90.18%-1.33M | 87.79%-15.02M | 100.58%360K | 166.71%13.84M | 31.38%-15.17M | 24.37%-13.55M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -96.57%475K | 117.63%2.65M | 110.56%758K | 108.66%1.31M | 90.18%-1.33M | 87.79%-15.02M | 100.58%360K | 166.71%13.84M | 31.38%-15.17M | 24.37%-13.55M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -97.07%0.0006 | 115.70%0.0035 | 80.00%0.0009 | 108.00%0.0018 | 90.00%-0.002 | 61.95%-0.0223 | 100.54%0.0005 | 141.00%0.0205 | 66.42%-0.0225 | 64.29%-0.02 |
| Diluted earnings per share | -97.07%0.0006 | 115.70%0.0035 | 80.00%0.0009 | 108.00%0.0018 | 90.00%-0.002 | 61.95%-0.0223 | 100.54%0.0005 | 141.00%0.0205 | 66.42%-0.0225 | 64.29%-0.02 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.